The Technical Analyst
Zomedica Pharmaceuticals [ZOM]
Exchange: AMEX Industry: Drug Manufacturers General Specialty & Generic
Zomedica Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals
-2.40% $0.126
America/New_York / 19 apr 2024 @ 15:11
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 123.67 mill |
| EPS: | -0.0400 |
| P/E: | -3.15 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 979.95 mill |
| Avg Daily Volume: | 4.78 mill |
| RATING 2024-04-19 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.15 | sector: PE 12.30 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -3.15 | industry: PE -13.90 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.116 - 0.134 ( +/- 7.21%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-15 | Powers Johnny D | Buy | 100 000 | Common Stock, without par value |
| 2023-12-15 | Powers Johnny D | Buy | 100 000 | Common Stock, without par value |
| 2023-11-17 | Powers Johnny D | Buy | 100 000 | Common Stock, without par value |
| 2023-11-17 | Heaton Larry C Ii | Buy | 100 000 | Common Stock, without par value |
| 2023-11-15 | Powers Johnny D | Buy | 150 000 | Common Stock, without par value |
| INSIDER POWER |
|---|
| 93.40 |
| Last 93 transactions |
| Buy: 92 487 495 | Sell: 14 772 509 |
Forecast:
16:00 - $0.126
Live Trading Signals (every 1 min)
Forecast
1: 15:19 - $0.125
Forecast 2: 16:00 - $0.126
Forecast 3: 16:00 - $0.126
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.126 (-2.40% ) |
| Volume | 4.95 mill |
| Avg. Vol. | 4.78 mill |
| % of Avg. Vol | 103.54 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ZOM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ZOM
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Latest Press Releases
2024-04-09 06:30:00 - Press Release
Zomedica To Present At The Noble Capital Markets Virtual Healthcare Conference On April 17, 2024
Ann arbor, mi / accesswire / april 9, 2024 / zomedica corp. (nyse american:zom) ("zomedica" or the "company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its chief executive officer, larry heaton, will present at the noble capital markets' emerging growth virtual healthcare equity conference on wednesday, april 17, 9:30 a.m. - 10:00 a.m.
2024-04-01 16:05:00 - Press Release
Zomedica Reports Record Revenue Of $7.3 Million For The Fourth Quarter And $25.2 Million For The Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin And $100.5 Million In Liquidity
Ann arbor, mi / accesswire / april 1, 2024 / zomedica corp. (nyse american:zom) ("zomedica" or the "company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today reported consolidated financial results for the fourth quarter and year-ended december 31, 2023. all figures are in us dollars unless otherwise stated.
2024-03-20 06:30:00 - Press Release
Zomedica To Report Fourth Quarter And Full Year 2023 Financial Results And Provide Business Update On Monday, April 1, 2024, At 4:30 P.m. Et
Ann arbor, mi / accesswire / march 20, 2024 / zomedica corp. (nyse american:zom) ("zomedica" or the "company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on monday, april 1st, 2024, at 4:30 p.m. et to discuss the company's operational and financial highlights for its fourth quarter and full year ended december 31, 2023.
2024-03-14 06:30:00 - Press Release
Zomedica Announces Publication Of Research Concluding Truforma(r) Platform Is More Accurate Diagnostic Test For Feline Hyperthyroidism Than Chemiluminescent Immunoassay (clia) Platform
Ann arbor, mi / accesswire / march 14, 2024 / zomedica corp. (nyse american:zom) ("zomedica" or the "company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the publication of a peer-reviewed research study favorably comparing the capabilities for the diagnosis of feline hyperthyroidism of its novel, point-of-care truforma bulk acoustic wave (baw) diagnostic platform to chemiluminescent immunoassay (clia) platforms currently broadly utilized by reference laboratories globally. the authors conclude that, "this new tsh-baw assay more accurately identifies hyperthyroid cats than the current tsh-clia assay and would improve the early diagnosis of hyperthyroidism.
2024-03-13 16:45:00 - Press Release
Zomedica Provides Nyse American Listing Update
Ann arbor, mi / accesswire / march 13, 2024 / zomedica corp. (nyse american:zom) ("zomedica" or the "company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that it is continuing dialogue with senior regulatory staff at the nyse american regarding next steps to regaining compliance with its listing standards. zomedica shares will remain listed on the nyse american at this time.
Latest News
2024-04-09 06:30:00 - Accesswire
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
ANN ARBOR, MI / ACCESSWIRE / April 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its Chief Executive Officer, Larry Heaton, will present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference on Wednesday, April 17, 9:30 a.m. - 10:00 a.m.
2024-04-01 20:49:07 - Seeking Alpha
Zomedica Corp. (ZOM) Q4 2023 Earnings Call Transcript
2024-04-01 15:12:11 - InvestorPlace
The Next Millionaire-Makers: 3 Penny Stocks With Massive Upside Potential
In investing, the allure of penny stocks attracts seasoned investors and newcomers alike. Small-cap stocks often trade on mere cents, but they can potentially yield massive returns.
2024-03-20 06:30:00 - Accesswire
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
ANN ARBOR, MI / ACCESSWIRE / March 20, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Monday, April 1st, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its fourth quarter and full year ended December 31, 2023.
2024-03-05 06:30:00 - Accesswire
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
ANN ARBOR, MI / ACCESSWIRE / March 5, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Small Cap Conference, taking place virtually on March 14th, 2024. The Company's presentation will take place at 10:00 am ET on Thursday, March 14, 2024, and can be accessed directly on the official Sidoti Conference website.
2024-02-11 11:22:43 - InvestorPlace
3 High-Reward Penny Stocks to Uncover Big Gains
Due to the fact that the stock market is in a constant state of flux, high-reward penny stocks often surface as hidden gems, luring purchasers with the promise of substantial rewards. Investing in such companies carries some risk but is a good way for smart investors to get rich.
2024-02-07 13:10:32 - InvestorPlace
7 Penny Stocks to Buy on the Dip: February 2024
Now might be a good time to consider scooping up shares of penny stocks to buy on the dip. However, caution is essential, as penny stocks can be volatile and speculative.
2024-02-05 12:40:04 - InvestorPlace
3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth
In stock market investments, identifying hidden gems can be the key to unlocking extraordinary wealth. It's akin to discovering a treasure trove — a gateway to unprecedented wealth and financial transformation.
2024-01-16 09:33:48 - InvestorPlace
3 Breakout Penny Stocks Primed for Massive Gains
In the volatile space of penny stocks, three companies are emerging as powerhouses with breakout potential, poised for massive gains. To begin with, the first one's organic growth, the second one's data licensing prowess in liquor retail, and the third one's strategic insurance advancements are captivating the market.
2024-01-10 06:30:00 - Accesswire
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024
ANN ARBOR, MI / ACCESSWIRE / January 10, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced that it will be hosting a conference call on Wednesday, January 17, 2024 at 4:30 p.m. ET. Management will provide a business update, including preliminary 2023 revenue and cash position, as well as other operational highlights during the call.